wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50115014-B4911EA9-C25B-4F01-860B-7ABA2357D3DA
Q50115014-B4911EA9-C25B-4F01-860B-7ABA2357D3DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50115014-B4911EA9-C25B-4F01-860B-7ABA2357D3DA
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
P2860
Q50115014-B4911EA9-C25B-4F01-860B-7ABA2357D3DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50115014-B4911EA9-C25B-4F01-860B-7ABA2357D3DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d65e06ca750679ee92a138ba74f809d79eca13a9
P2860
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.